drug information centers (dics)
DESCRIPTION
Drug Information Centers (DICs). Outline. Define drug information and related terms History of drug information Drug information center goals ASHP effective provider of drug information The pharmacist role Considerations of DIC Systematic method for responding to requests - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/1.jpg)
Drug Information Centers(DICs)
![Page 2: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/2.jpg)
Define drug information and related terms History of drug information Drug information center goals ASHP effective provider of drug information The pharmacist role Considerations of DIC Systematic method for responding to requests Documentation and quality assessment of drug
information requests
Outline
![Page 3: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/3.jpg)
Drug Information is the provision of unbiased, well-referenced, and critically evaluated information on any aspect of pharmacy practice
Drug Information Center is to provide a system for the organization and dissemination of drug information (Francke 1965)
Drug Informatics emphasizes the use of technology as an integral tool in effectively organizing, analyzing and managing information on medications
Definitions
Yousif Abdu Asiri, The Difference Between Drug Information Center (DIC) and Poison Control Center (PCC).Power Point Presentation
![Page 4: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/4.jpg)
1960s Development of the term ‘’drug information’’
1962 First drug information center at the University of Kentucky Medical Center, USA
1964 Conference on Drug Information Services
1967 The ‘’Drug Information Specialist’’
1975 The Millis Commission Report, AACP described the main function of pharmacists as
providers of drug information
History
Yousif Abdu Asiri, The Difference Between Drug Information Center (DIC) and Poison Control Center (PCC).Power Point Presentation
![Page 5: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/5.jpg)
To stimulate the effective use of drug information resources by pharmacists, physicians, and other health care professionals
To educate pharmacy students to serve as effective providers of drug information
To provide an organized database of specialized information on drug therapeutics to meet the drug information needs of practitioners
Drug Information Center Goals
![Page 6: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/6.jpg)
To expand the role of the pharmacist in providing drug information services to the hospital and community
To promote patient care through rational drug therapy by the improved availability and use of drug information
Drug Information Center Goals
![Page 7: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/7.jpg)
1. Perceive and evaluate the medication information needs of patients and families, health care professionals, and other personnel
ASHP: Effective Provider of Drug Information Should:
ASHP, Am J Health-Syst Pharm. 1996; 53:1843–5
![Page 8: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/8.jpg)
2. Use a systematic approach to address medication information needs by effectively:◦ Searching literature ◦ Retrieving literature◦ Evaluating literature◦ Appropriately communicating information◦ Applying the information to the patient care situation
ASHP: Effective Provider of Drug Information Should:
ASHP, Am J Health-Syst Pharm. 1996; 53:1843–5
![Page 9: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/9.jpg)
1. Providing medication information to patients & families, health care professionals, and other personnel
2. Establishing and maintaining a formulary based on scientific evidence of efficacy and safety, cost, and patient factors
3. Developing and participating in efforts to prevent medication misadventuring, including adverse drug event and medication error reporting and analysis programs
The Pharmacist Role
ASHP, Am J Health-Syst Pharm. 1996; 53:1843–5
![Page 10: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/10.jpg)
4. Developing methods of changing patient and provider behaviors to support optimal medication use
5. Publishing newsletters to educate patients, families, and health care professionals on medication use
6. Educating providers about medication-related policies and procedures
The Pharmacist Role - Cont’d
ASHP, Am J Health-Syst Pharm. 1996; 53:1843–5
![Page 11: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/11.jpg)
7. Coordinating programs to support population based medication practices (e.g. development of medication-use evaluation criteria and pharmacotherapeutic guidelines)
8. Coordinating investigational drug services
9. Providing continuing-education services to the healthcare professional staff
The Pharmacist Role - Cont’d
ASHP, Am J Health-Syst Pharm. 1996; 53:1843–5
![Page 12: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/12.jpg)
10. Educating pharmacy students and residents
11. Applying health economic and outcome analysis
12. Developing and maintaining an active research program
The Pharmacist Role - Cont’d
ASHP, Am J Health-Syst Pharm. 1996; 53:1843–5
![Page 13: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/13.jpg)
Types of Drug Information Centers
Hospital based Industry based Community based
Yousif Abdu Asiri, The Difference Between Drug Information Center (DIC) and Poison Control Center (PCC).Power Point Presentation
![Page 14: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/14.jpg)
Considerations of DICA) Equipments
1. Telephone: the lines should be designed to allow immediate, direct access to the center
2. Computers
3. Fax machine
4. Printer
5. Copier machine
![Page 15: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/15.jpg)
Value of Computers in Provision of Drug Information Databases are available for information management,
retrieval, and communication
Information management databases include software for MUE, documentation of questions and responses, and preparation of reports of adverse drug events
Information retrieval sources include bibliographic
databases (e.g., International Pharmaceutical Abstracts, Iowa Drug Information Service, MEDLINE) and full-text databases (e.g., Drug Information Fulltext)
![Page 16: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/16.jpg)
Value of Computers in Provision of Drug Information Textbooks (e.g., AHFS Drug Information) and journals
can also be accessed through computer technology
Some information is available through electronic bulletin boards (e.g., PharmNet) and the Internet
Computerized medical records can also be a valuable tool in assessing either individual patient needs or population-based needs
![Page 17: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/17.jpg)
Consideration of DICB) Specific Area
It should be close to the pharmacy department to allow both pharmacy staff & other healthcare providers to reach it easily
A sign or label on the door the to specify who will be allowed to enter the DIC room
It can be inside the pharmacy department
![Page 18: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/18.jpg)
Considerations of DICC) Personnel
Specific Criteria: ◦ Pharm.D degree, MS degree, BS degree with
specialized training in drug information center, experience minimum 1-2 years, residency, fellowship
General Criteria :◦ Computers skills◦ The person should be cooperative, confident,
accurate, good English language
![Page 19: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/19.jpg)
Considerations of DICD) Resources
Types of Resources:
◦ Tertiary Resources (textbooks, review articles)
◦ Secondary Resources (index and abstract primary resources with the goal of directing user to primary resources)
◦ Primary resources (journals) Not all articles are considered primary resources !!!
![Page 20: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/20.jpg)
Considerations of DICD) Resources - Cont’d It is the responsibility of the pharmacist to ensure that
up-to-date resources are available
Pharmacists should be familiar with not only the components of the literature (e.g. primary) but also the features of individual resources in each component
◦ this makes searching more efficient so that time can be used optimally in analyzing, applying, & communicating the information
![Page 21: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/21.jpg)
1. Consider the education and professional or experiential background of the requester
2. Identify needs by asking probing questions or by examining the medical record to identify the true question. Assess the urgency for a response
3. Classify requests as patient-specific or not and by type of question to aid in assessing the situation and selecting resources
Systematic Method for Responding to Drug Information Requests
ASHP, Am J Health-Syst Pharm. 1996; 53:1843–5
![Page 22: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/22.jpg)
Product availability, Adverse drug event Compatibility Compounding/formulation Dosage/administration Drug interaction
Types of Questions Identification Pharmacokinetics therapeutic use/efficacy Safety in pregnancy and
nursing Toxicity and poisoning Articles/Reviews
![Page 23: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/23.jpg)
4. Obtain more complete background information, including patient data to individualize the response to meet the patient’s, family’s, or health care professional’s needs
5. Perform a systematic search of the literature by making appropriate selections from the primary, secondary, and tertiary literature
6. Evaluate, interpret, and combine information from the several sources. Other information needs should be anticipated as a result of the information provided
Systematic Method for Responding to Drug Information Requests
ASHP, Am J Health-Syst Pharm. 1996; 53:1843–5
![Page 24: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/24.jpg)
7. Provide a response by written or oral consultation, or both, as needed by the requester and appropriate to the situation
8. Perform a follow-up assessment to determine the utility of the information provided and outcomes for the patient
9. Document the request, information sources, response, and follow-up as appropriate
Systematic Method for Responding to Drug Information Requests
ASHP, Am J Health-Syst Pharm. 1996; 53:1843–5
![Page 25: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/25.jpg)
1. Date and time received2. Requester’s name, address, method of contact (e.g.,
telephone or beeper number), and category (e.g., health care discipline, patient, public)
3. Person assessing medication information needs4. Method of delivery (e.g., telephone, personal visit, mail).5. Classification of request6. Question asked7. Patient-specific information obtained
Documentation of Drug Information Requests
ASHP, Am J Health-Syst Pharm. 1996; 53:1843–5
![Page 26: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/26.jpg)
8. Response provided9. References used10. Date and time answered11. Person responding to request12. Estimated time in preparation and for communication13. Materials sent to requesters14. Outcome measures suggested (e.g., impact on patient
care, improvements in medication use, and requester satisfaction)
Documentation of Drug Information Requests
ASHP, Am J Health-Syst Pharm. 1996; 53:1843–5
![Page 27: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/27.jpg)
Responses to requests for medication information should be accurate, complete, and timely for:
◦ maximal clinical usefulness◦ to establish credibility for pharmacist-provided
information
Quality Assessment
ASHP, Am J Health-Syst Pharm. 1996; 53:1843–5
![Page 28: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/28.jpg)
Quality assessment of responses could be selective for:
◦ certain types of patient-specific requests◦ random by numbers of requests ◦ for certain time periods
Quality Assessment
ASHP, Am J Health-Syst Pharm. 1996; 53:1843–5
![Page 29: Drug Information Centers (DICs)](https://reader033.vdocuments.mx/reader033/viewer/2022052118/56816391550346895dd4878b/html5/thumbnails/29.jpg)
It is the responsibility of the pharmacist to keep abreast of advancements both
◦ in the tools that can be used to systematically address information requests
And
◦ in the information itself regarding pharmacotherapeutic or other issues affecting the practice of pharmacy
Keeping Current
ASHP, Am J Health-Syst Pharm. 1996; 53:1843–5